Table 3.
Frequency of adverse events in respective treatment group
| Adverse events | ||
|---|---|---|
| MPH | Placebo | |
| n = 27 | n = 27 | |
| Headache | 6 | 2 |
| Abdominal discomfort | 6 | 1 |
| Sleep problems | 6 | 2 |
| Loss of appetite | 7 | 0 |
| Depressed mood | 3 | 4 |
| Increased blood pressure | 2 | 4 |
| Sweating | 5 | 1 |
| Fatigue | 3 | 3 |
| Anxiety | 1 | 4 |
| Dry mouth | 2 | 1 |
| Craving | 1 | 2 |
| Chest pain | 1 | 2 |
| Muscular pain | 1 | 2 |
| Restlessness | 1 | 1 |
| Procrastination | 2 | 0 |
| Dizziness | 1 | 1 |
| Skin problems | 2 | 0 |
| Hears voices | 0 | 1 |
| Palpitations | 0 | 1 |
| Tics | 0 | 1 |
| Agitation | 0 | 1 |
| Lower self-esteem | 0 | 1 |
| Suicidal ideation | 0 | 1 |
MPH = methylphenidate.